OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cancer-associated fibroblasts as therapeutic targets for cancer: advances, challenges, and future prospects
Zhipeng Cao, Sadia Quazi, Sakshi Arora, et al.
Journal of Biomedical Science (2025) Vol. 32, Iss. 1
Open Access | Times Cited: 6

Showing 6 citing articles:

Deciphering the mechanisms of PARP inhibitor resistance in prostate cancer: Implications for precision medicine
Cheng Wang, Xiaoran Han, Shaoqiu Kong, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 185, pp. 117955-117955
Closed Access

Mechanistic role of stromal cancer-associated fibroblasts in tumorigenesis and brain metastasis: highlighting drug resistance and targeted therapy
Md Rashedunnabi Akanda, Umme Lubaba, Md Khalesur Rahman, et al.
Pathology - Research and Practice (2025), pp. 155918-155918
Closed Access

Extracellular vesicles in cancer´s communication: messages we can read and how to answer
Alena Semerádtová, Michaela Liegertová, Regina Herma, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access

Understanding Merkel Cell Carcinoma: Pathogenic Signaling, Extracellular Matrix Dynamics, and Novel Treatment Approaches
Maria Konstantaraki, Aikaterini Berdiaki, Monica Neagu, et al.
Cancers (2025) Vol. 17, Iss. 7, pp. 1212-1212
Open Access

Revisiting the role of cancer-associated fibroblasts in tumor microenvironment
Xiaolei Lan, Wenyang Li, Kai Zhao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

A first-in-class inhibitor of homologous recombination DNA repair counteracts tumour growth, metastasis and therapeutic resistance in pancreatic cancer
Juliana Calheiros, Rita Silva, Filipa Barbosa, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Page 1

Scroll to top